WS Audiology (WSA) reported 2% organic revenue growth for the fiscal year that ended September 30, 2026, as gains in its consumer-facing businesses offset a decline in wholesale. In a press release , the company said it met its sales and profitability guidance, but expects margins to fall in the coming year after a major U.S. managed care contract expires in January....
Continue reading at Hearing Tracker
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable clinical change — this is a financial performance report with no direct implications for hearing care practice.
WSA's managed care contract loss could signal tightening of insurance-covered hearing aid access in the U.S., which may affect patient referral pathways and clinic revenue.
- 01WS Audiology posted 2% organic revenue growth for FY ending September 30, 2026.
- 02Results met company guidance but were not above expectations.
- 03A lost U.S. managed care contract is flagged as a risk to future margins.
- 04WSA owns major brands Signia and Widex.
- 05Margin pressure from the contract loss may affect U.S. distribution strategies.
WS Audiology achieved 2% organic revenue growth for the fiscal year ending September 30, 2026.
press releasesupportedA lost U.S. managed care contract is creating margin pressure and clouding the company's outlook.
press releasesupported